cetuximab,paclitaxel
eli lilly
['scchn', 'cetuximab', 'paclitaxel', 'head and neck']
#esmo22 ttcc-2019-02 real world evidence of first-line cetuximab (cx) plus paclitaxel (px) in recurrent or metastatic squamous cell carcinoma of the head and neck (scchn). have a look: poster 678. 
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello - Spanish Head and Neck Cancer Cooperative Group- 2001